Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
ESOMEPRAZOLE MAGNESIUM (AMORPHOUS)
Teva Pharma B.V.
40 Milligram
Tablets Gastro-Resistant
2011-02-25
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Esomeprazole 40 mg Gastro-resistant Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: 40 mg esomeprazole as esomeprazole magnesium (amorphous). Excipients: Each tablet also contains not more than 54.90 mg Sucrose. For full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Gastro-resistant tablet Light brick red to brown coloured, oval, biconvex, film-coated tablets with ‘E6’ debossed on one side and plain on other side 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Esomeprazole 40 mg Gastro-resistant tablets are indicated for: GASTROESOPHAGEAL REFLUX DISEASE (GERD) treatment of erosive reflux esophagitis Prolonged treatment after IV induced prevention of rebleeding of peptic ulcers Treatment of Zollinger Ellison Syndrome 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The tablets should be swallowed whole with liquid. The tablets should not be chewed or crushed. For patients who have difficulty in swallowing the tablets can also be dispersed in half a glass of non-carbonated water. No other liquids should be used as the enteric coating may be dissolved. Stir until the tablets disintegrate and drink the liquid with the pellets immediately or within 30 minutes. Rinse the glass with half a glass of water and drink. The pellets must not be chewed or crushed. For patients who cannot swallow, the tablets can be dispersed in non-carbonated water and administered through a gastric tube. It is important that the appropriateness of the selected syringe and tube is carefully tested. For preparation and administration instructions see section 6.6. Adults and adolescents from the age of 12 years GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD) - treatment of erosive reflux esophagitis 40 mg once daily f Read the complete document